• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有甲硫基咪唑取代基的硝苯地平类似物的合成及钙通道拮抗剂活性

Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent.

作者信息

Foroumadi A, Analuie N, Rezvanipour M, Sepehri G, Najafipour H, Sepehri H, Javanmardi K, Esmaeeli F

机构信息

Kerman University of Medical Sciences, Research Center, Iran.

出版信息

Farmaco. 2002 Mar;57(3):195-9. doi: 10.1016/s0014-827x(01)01191-0.

DOI:10.1016/s0014-827x(01)01191-0
PMID:11989797
Abstract

Various diester analogues of nifedipine, in which the orthonitrophenyl group at position 4 is replaced by 1-methyl-2-methylthio-5-imidazolyl substituent, were synthesized and evaluated as calcium channel antagonists on guinea-pig ileal smooth muscle. Nifedipine was used as standard. Comparison of the activities of symmetrical esters (3a-e) indicate that increasing the length of alkyl chain in C3 and C5 ester substituents increases the antagonist activity and the n-propyl ester being preferred (IC50= 2.66 x 10(-9) M). In asymmetrical series (6a-g), compound 6g having ethyl and n-butyl ester at C3 and C5 positions of basic dihydropyridine structure was found to be the most active (IC50= 1.32 x 10(-9) M).

摘要

合成了硝苯地平的各种二酯类似物,其中4位的邻硝基苯基被1-甲基-2-甲硫基-5-咪唑基取代基取代,并在豚鼠回肠平滑肌上作为钙通道拮抗剂进行了评估。硝苯地平用作标准品。对称酯(3a-e)活性的比较表明,增加C3和C5酯取代基中烷基链的长度会增加拮抗剂活性,正丙酯为首选(IC50 = 2.66×10(-9)M)。在不对称系列(6a-g)中,发现在碱性二氢吡啶结构的C3和C5位置具有乙酯和正丁酯的化合物6g活性最高(IC50 = 1.32×10(-9)M)。

相似文献

1
Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent.具有甲硫基咪唑取代基的硝苯地平类似物的合成及钙通道拮抗剂活性
Farmaco. 2002 Mar;57(3):195-9. doi: 10.1016/s0014-827x(01)01191-0.
2
Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.含4-(5)-氯-2-乙基-5-(4)-咪唑基取代基的新型1,4-二氢吡啶的设计、合成及钙通道拮抗剂活性
Arch Pharm (Weinheim). 2006 Jun;339(6):299-304. doi: 10.1002/ardp.200600013.
3
Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.含4(5)-氯-2-甲基-5(4)-咪唑基取代基的硝苯地平类似物的合成及钙通道拮抗剂活性
Boll Chim Farm. 2001 Nov-Dec;140(6):381-6.
4
Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.含硝基苄基咪唑基取代基的新型1,4 - 二氢吡啶在豚鼠回肠平滑肌中的合成及钙拮抗剂活性
Boll Chim Farm. 2002 Jan-Feb;141(1):15-20.
5
Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.含1-甲基-4,5-二氯咪唑基取代基的新型1,4-二氢吡啶衍生物的合成、定量构效关系及钙通道拮抗剂活性
Arch Pharm (Weinheim). 2007 Oct;340(10):549-56. doi: 10.1002/ardp.200600211.
6
Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates.
Boll Chim Farm. 2003 May;142(4):175-9.
7
Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.设计和合成含 4(5)-氯-5(4)-咪唑基取代基的新型 1,4-二氢吡啶类化合物作为新型钙通道阻滞剂。
Arch Pharm Res. 2011 Sep;34(9):1417-26. doi: 10.1007/s12272-011-0902-9. Epub 2011 Oct 6.
8
Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.含亲脂性4-咪唑基取代基的新型1,4-二氢吡啶衍生物的合成及其钙通道拮抗剂活性
Arzneimittelforschung. 2004;54(9):499-504. doi: 10.1055/s-0031-1297004.
9
Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents.含苯氨基咪唑基取代基的1,4 - 二氢吡啶的合成及钙拮抗剂活性
Farmaco. 2003 Nov;58(11):1077-81. doi: 10.1016/S0014-827X(03)00159-9.
10
Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents.含4-硝基咪唑基取代基的1,4-二氢吡啶衍生物的合成及钙通道拮抗剂活性
Arzneimittelforschung. 2002;52(7):537-42. doi: 10.1055/s-0031-1299927.

引用本文的文献

1
Synthesis of Novel 1,4- Dihydropyridine Derivatives Bearing Biphenyl-2'-Tetrazole Substitution as Potential Dual Angiotensin II Receptors and Calcium Channel Blockers.新型含联苯 - 2'- 四唑取代基的1,4 - 二氢吡啶衍生物的合成:潜在的双重血管紧张素II受体和钙通道阻滞剂
Adv Pharm Bull. 2011;1(1):1-9. doi: 10.5681/apb.2011.001. Epub 2011 Jul 20.